Skip to main content

Table 1 Number of cases of bowel perforation following treatment with carboplatin and paclitaxel in the literature

From: Rectal perforation following paclitaxel and carboplatin chemotherapy for advanced ovarian cancer: a case report and review of the literature

Author(s) and reference number

Title of article

Type of cancer

Journal

Volume

Year

Number of cases reported

Samejima et al. [8]

Rectal perforation in a patient treated with combination chemotherapy for lung cancer

Lung cancer

Gan To Kagaku Ryoho

36(2):301–4

2009

1

de Haan and van den Berg [4]

Colonic perforation secondary to taxol therapy: an unusual presentation

Ovarian cancer

Onkologie

29(11):541–2

2006

1

Rose and Piver [5]

Intestinal perforation secondary to paclitaxel

Ovarian cancer

Gynecologic Oncology

57(2):270–2

1995

3

Seewaldt et al. [10]

Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trial

Ovarian cancer

Am J Obstet Gynecol

170(6):1666–70

1994

4

Carter and Durfee [7]

A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer

Ovarian cancer

Gynecologic Oncology

107(3):586–9

2007

1

  1. Table 1 indicates the number of cases of colonic perforation mentioned in the literature following treatment with paclitaxel. It indicates the type of malignancy being treated and the total number of cases detected. The journals found include non-English journals